Aziyo Biologics, Inc.
Hedge Funds Holdings

Last updated:

Aziyo Biologics, Inc.‘s stocks are currently a part of 12 hedge funds’ portfolios, which represents 16.08% of the total amount of its stocks outstanding. This makes up a total of 2.22M shares of Aziyo Biologics, Inc.. Compared to the previous quarter, the number fell by -48.03% or -2.05M shares fewer. As for the holding position changes, 50% (6) of current hedge fund investors increased the number of shares held, 16.67% (2) of current holders sold a part of the shares held, and 16.67% (2) closed the holdings completely. 3 hedge funds are new holders of Aziyo Biologics, Inc. stock in Q1 2023, it is 25% of total holders.

Hedge funds holding Aziyo Biologics (Q4 2020 – Q1 2023)

Number of hedge funds
Q4 2020 34
Q1 2021 31
Q2 2021 20
Q3 2021 16
Q4 2021 13
Q1 2022 15
Q2 2022 16
Q3 2022 15
Q4 2022 18
Q1 2023 12

Hedge funds changes in Aziyo Biologics positions (Q4 2020 – Q1 2023)

Changes in positions
Q4 2020 340000
Q1 2021 2121052
Q2 2021 47615-12
Q3 2021 1765-3
Q4 2021 04531
Q1 2022 21606
Q2 2022 25414
Q3 2022 13425
Q4 2022 48213
Q1 2023 3622-1

Top 50 hedge fund holders of Aziyo Biologics, Inc. (NASDAQ:AZYO)

Hedge fund Value Shares owned Portfolio share
BIRCHVIEW CAPITAL, LP 10.21M 1.41M 7.190%
ENDURANT CAPITAL MANAGEMENT LP 8.20M 1.13M 2.673%
BROWN ADVISORY INC 1.66M 230.66K 0.003%
PERKINS CAPITAL MANAGEMENT INC 1.57M 218.32K 1.759%
PLATINUM INVESTMENT MANAGEMENT LTD 1.35M 188.18K 0.057%
VANGUARD GROUP INC 544K 75.56K 0.000%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 179K 24.9K 0.005%
MILLENNIUM MANAGEMENT LLC Israel Englander 83K 11.58K 0.000%
GEODE CAPITAL MANAGEMENT, LLC 76K 10.67K 0.000%
BLACKROCK INC. Larry Fink 67K 9.39K 0.000%
MORGAN STANLEY 26K 3.65K 0.000%
US BANCORP \DE\ 5K 625 0.000%
UBS GROUP AG 5K 689 0.000%
BANK OF AMERICA CORP /DE/ 3K 350 0.000%
TOWER RESEARCH CAPITAL LLC (TRC) 1K 151 0.000%
NISA INVESTMENT ADVISORS, LLC 0 0 0.000%
BARCLAYS PLC 0 0 0.000%